-
Air Pollution Compounds SARS-CoV-2, Daily Aspirin Reduces Death Risk, NYC Cases Linked To Europe: COVID-19 Updates
Clinical Research News I Acuity score predicts outcomes, elderly population at highest risk for COVID-19 death in care homes, Black Hispanics suffering worst outcomes, death rates drop by half in England, healthcare workers and their families account for a sixth of hospital admissions, and the pandemic will profoundly affect births and gender roles. Plus: Diabetic kidney disease cells resemble COVID-19 damaged kidneys, one third of patients given EEG have frontal lobe abnormalities, most people develop strong antibodies that last months, recovered individuals may be asymptomatic carriers, many COVID-19 patients have vitamin D deficiency, and vaccine tracker provides real-time updates.
Oct 30, 2020
-
AiCure Announce Open Source Computer Vision Platform
Clinical Research News Online | AiCure has announced OpenDBM, an open-source version of its computer vision and AI-powered digital biomarker platform. The platform's transparent framework will give the scientific community access to AiCure's digital biomarker algorithms.
Oct 29, 2020
-
Streamlining Data Management In Clinical Trials With Artificial Intelligence And Machine Learning
Clinical Research News | Quality, accurate, and comprehensive clinical trial data are essential for a successful clinical trial. Without this information, companies cannot ensure the safety and efficacy standards that will pass regulatory review.
Oct 29, 2020
-
Follow the Money: Wearables for Clinical Research, Trials for Vaccine Patches
Clinical Research News | Wearables for clinical research, clinical trials launch for a vaccine patch that doesn’t require refrigeration, exploring therapeutics for preterm birth, Sickle Cell Disease treatments, and more.
Oct 28, 2020
-
Open Wearables Initiative Seeks Industry Data, Algorithms
Clinical Research News | The Open Wearables Initiative (OWEAR) is evaluating a significant expansion of its vision and seeking industry input to build consensus.
Oct 27, 2020
-
Why Diversity Matters: COVID-19 and the Search for a Vaccine
Clinical Research News | As the pandemic continues, infecting over 30 million people and killing more than 1 million worldwide, emerging data suggest that COVID-19 is disproportionately impacting communities of color, and as scientists race ahead to develop a safe and effective vaccine, some experts have highlighted the need to address the lack of diversity in clinical trials considering the populations at greatest risk stand to benefit the most from this research.
Oct 27, 2020